Sandra K. Wittmann

824 total citations
22 papers, 603 citations indexed

About

Sandra K. Wittmann is a scholar working on Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, Sandra K. Wittmann has authored 22 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biochemistry, 7 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Sandra K. Wittmann's work include Eicosanoids and Hypertension Pharmacology (10 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Sandra K. Wittmann is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (10 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Sandra K. Wittmann collaborates with scholars based in Germany, Canada and Austria. Sandra K. Wittmann's co-authors include Christoph Daniel, Christian Hugo, Ewgenij Proschak, Dieter Steinhilber, Lilia Weizel, Rolf Morosoli, D. Kluepfel, F. Shareck, Jan S. Kramer and Franca‐Maria Klingler and has published in prestigious journals such as Nature Communications, Applied and Environmental Microbiology and Analytical Biochemistry.

In The Last Decade

Sandra K. Wittmann

22 papers receiving 600 citations

Peers

Sandra K. Wittmann
Yashang Lee United States
Raffaella Franca Italy
Gawain Williams United States
Xiaojia Guo United States
Iwao Yamada Japan
Azuma Watanabe Japan
Mary C. Ritter United States
Zhaolin Sun China
Kazuyuki Kubota Japan
Masaki Ishigai United States
Yashang Lee United States
Sandra K. Wittmann
Citations per year, relative to Sandra K. Wittmann Sandra K. Wittmann (= 1×) peers Yashang Lee

Countries citing papers authored by Sandra K. Wittmann

Since Specialization
Citations

This map shows the geographic impact of Sandra K. Wittmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra K. Wittmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra K. Wittmann more than expected).

Fields of papers citing papers by Sandra K. Wittmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra K. Wittmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra K. Wittmann. The network helps show where Sandra K. Wittmann may publish in the future.

Co-authorship network of co-authors of Sandra K. Wittmann

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra K. Wittmann. A scholar is included among the top collaborators of Sandra K. Wittmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra K. Wittmann. Sandra K. Wittmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hiesinger, Kerstin, Jan S. Kramer, René Blöcher, et al.. (2019). Design of Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase. ACS Medicinal Chemistry Letters. 11(3). 298–302. 10 indexed citations
2.
Scholz, M., et al.. (2019). Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophores. European Journal of Medicinal Chemistry. 185. 111766–111766. 7 indexed citations
3.
Heering, Jan, Daniel Merk, Carlo Angioni, et al.. (2019). Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ. Frontiers in Pharmacology. 10. 263–263. 20 indexed citations
4.
Hiesinger, Kerstin, Jan S. Kramer, Júlia Wéber, et al.. (2019). Computer-Aided Selective Optimization of Side Activities of Talinolol. ACS Medicinal Chemistry Letters. 10(6). 899–903. 6 indexed citations
5.
Kramer, Jan S., Sandra K. Wittmann, Jörn Lausen, et al.. (2018). A coupled fluorescence-based assay for the detection of protein arginine N-methyltransferase 6 (PRMT6) enzymatic activity. Analytical Biochemistry. 547. 7–13. 3 indexed citations
6.
Wittmann, Sandra K., Duran Sürün, Meike J. Saul, et al.. (2017). Characterization and cellular localization of human 5-lipoxygenase and its protein isoforms 5-LOΔ13, 5-LOΔ4 and 5-LOp12. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1862(5). 561–571. 6 indexed citations
7.
Garscha, Ulrike, Simona Pace, Antonietta Rossi, et al.. (2017). Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase. Scientific Reports. 7(1). 9398–9398. 38 indexed citations
8.
Kramer, Jan S., Franca‐Maria Klingler, Sandra K. Wittmann, et al.. (2017). Challenges in the Development of a Thiol-Based Broad-Spectrum Inhibitor for Metallo-β-Lactamases. ACS Infectious Diseases. 4(3). 360–372. 51 indexed citations
9.
Schmidt, Jurema, Sandra K. Wittmann, Lilia Weizel, et al.. (2017). A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis. Journal of Medicinal Chemistry. 60(18). 7703–7724. 72 indexed citations
10.
Klingler, Franca‐Maria, Markus Wolf, Sandra K. Wittmann, Philip Gribbon, & Ewgenij Proschak. (2016). Bacterial Expression and HTS Assessment of Soluble Epoxide Hydrolase Phosphatase. SLAS DISCOVERY. 21(7). 689–694. 10 indexed citations
11.
Wittmann, Sandra K., Jan S. Kramer, Stefan Knapp, et al.. (2016). Thermodynamic properties of leukotriene A4 hydrolase inhibitors. Bioorganic & Medicinal Chemistry. 24(21). 5243–5248. 14 indexed citations
12.
Wittmann, Sandra K., Jan S. Kramer, René Blöcher, et al.. (2015). PENG: A Neural Gas-Based Approach for Pharmacophore Elucidation. Method Design, Validation, and Virtual Screening for Novel Ligands of LTA4H. Journal of Chemical Information and Modeling. 55(2). 284–293. 14 indexed citations
13.
Kolodziej, Stephan, Olga N. Kuvardina, Thomas Oellerich, et al.. (2014). PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation. Nature Communications. 5(1). 3995–3995. 56 indexed citations
14.
George, Sven, Ann‐Kathrin Häfner, Franca‐Maria Klingler, et al.. (2013). Synthesis and Structure–Activity Relationship Studies of Novel Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase. Journal of Medicinal Chemistry. 56(4). 1777–1781. 31 indexed citations
15.
Meister, Silke, Eva Gückel, C. Starke, et al.. (2010). Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat. Nephrology Dialysis Transplantation. 25(11). 3764–3773. 44 indexed citations
16.
Wittmann, Sandra K., et al.. (2009). Long-Term Treatment of Sirolimus but Not Cyclosporine Ameliorates Diabetic Nephropathy in the Rat. Transplantation. 87(9). 1290–1299. 46 indexed citations
17.
Wittmann, Sandra K., et al.. (2008). The mTOR Inhibitor Everolimus Attenuates the Time Course of Chronic Anti-Thy1 Nephritis in the Rat. Nephron Experimental Nephrology. 108(2). e45–e56. 21 indexed citations
18.
Hohenstein, Bernd, Christoph Daniel, Sandra K. Wittmann, & Christian Hugo. (2008). PDE-5 inhibition impedes TSP-1 expression, TGF-  activation and matrix accumulation in experimental glomerulonephritis. Nephrology Dialysis Transplantation. 23(11). 3427–3436. 26 indexed citations
19.
Wittmann, Sandra K., et al.. (2007). The mTOR Inhibitor Everolimus Induces Proteinuria and Renal Deterioration in the Remnant Kidney Model in the Rat. Transplantation. 84(11). 1492–1499. 65 indexed citations
20.
Wittmann, Sandra K., F. Shareck, D. Kluepfel, & Rolf Morosoli. (1994). Purification and characterization of the CelB endoglucanase from Streptomyces lividans 66 and DNA sequence of the encoding gene. Applied and Environmental Microbiology. 60(5). 1701–1703. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yashang Lee Breakdown of academic impact, for papers by Raffaella Franca Breakdown of academic impact, for papers by Gawain Williams Breakdown of academic impact, for papers by Xiaojia Guo Breakdown of academic impact, for papers by Iwao Yamada Breakdown of academic impact, for papers by Azuma Watanabe Breakdown of academic impact, for papers by Mary C. Ritter Breakdown of academic impact, for papers by Zhaolin Sun Breakdown of academic impact, for papers by Kazuyuki Kubota Breakdown of academic impact, for papers by Masaki Ishigai
Rankless by CCL
2026